# Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19

> **NCT04363047** · — · ENROLLING_BY_INVITATION · sponsor: **University of Manchester** · enrollment: 125 (estimated)

## Conditions studied

- SARS Virus

## Interventions

- **OTHER:** 40ml blood sample

## Key facts

- **NCT ID:** NCT04363047
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2020-10-01
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04363047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04363047, "Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04363047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*